New

Carbetocin Injection Market

2021

Carbetocin Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Original Drug, Generic Drug); End-user (Hospitals, Clinics, Other) and Geography

| Report Code: TIPRE00023795 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Carbetocin Injection Market 2028 By Type, End-user and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Carbetocin is a drug medication used to prevent excessive bleeding (postpartum hemorrhage) after giving birth, particularly following cesarean section. The drug is an analog of oxytocin and works similar to that of oxytocin. It is administered by injection in the vein or muscle. A single dose of this drug act as 16 hours intravenous oxytocin infusion regarding the increase in uterine tone.

MARKET SCOPE

The "Global Carbetocin Injection Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the carbetocin injection market with detailed market segmentation by type, end user, and geography. The report provides key statistics on the market status of the leading carbetocin injection market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

    - Based on type, the global carbetocin injection market is segmented into original drug and generic drug.
    - On the basis of end-users, the market is bifurcated into hospitals, clinics and other.

MARKET DYNAMICS
Drivers:

    - Increasing incidences of postpartum hemorrhage and increasing birth rate drive the carbetocin injection market growth.
    - Growing research & development activities and the introduction of technologically advanced products fuel market growth.
    - Advanced facilities in hospital infrastructure in developing countries propel market growth.

Restraints:

    - Repeated or overdosage of the drug causes various problems.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The carbetocin injection market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the carbetocin injection market in these regions.

IMPACT OF COVID-19 ON CARBETOCIN INJECTION MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Due to the pandemic, the worldwide pharmaceutical market was affected. The worldwide lockdown, supply and production chain disruption, and business shutdown have impacted the market's growth. Non-essential surgeries were postponed, and only emergency procedures were allowed to be carried out. Hence, the above-mentioned factors affected the development of the carbetocin market in the pandemic period.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the carbetocin injection market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from carbetocin injection market are anticipated to have lucrative growth opportunities in the future with the rising demand for carbetocin injection in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the carbetocin injection market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    - Ferring Pharmaceuticals
    - Hybio Pharmaceutical
    - Pfizer
    - Beacon Pharmaceuticals Ltd.
    - Chengdu Shengnuo Biotechnology
    - Tibet Aim Pharm Inc (Aim Pharm)
    - SGPharma
    - Smokin Joe
    - MDA INC.
    - Taj Pharmaceuticals
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Carbetocin Injection Market - By Type
1.3.2 Carbetocin Injection Market - By End-user
1.3.3 Carbetocin Injection Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. CARBETOCIN INJECTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. CARBETOCIN INJECTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CARBETOCIN INJECTION MARKET - GLOBAL MARKET ANALYSIS
6.1. CARBETOCIN INJECTION - GLOBAL MARKET OVERVIEW
6.2. CARBETOCIN INJECTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. CARBETOCIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ORIGINAL DRUG
7.3.1. Overview
7.3.2. Original Drug Market Forecast and Analysis
7.4. GENERIC DRUG
7.4.1. Overview
7.4.2. Generic Drug Market Forecast and Analysis
8. CARBETOCIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis

9. CARBETOCIN INJECTION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Carbetocin Injection Market Overview
9.1.2 North America Carbetocin Injection Market Forecasts and Analysis
9.1.3 North America Carbetocin Injection Market Forecasts and Analysis - By Type
9.1.4 North America Carbetocin Injection Market Forecasts and Analysis - By End-user
9.1.5 North America Carbetocin Injection Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Carbetocin Injection Market
9.1.5.1.1 Canada Carbetocin Injection Market by Type
9.1.5.1.2 Canada Carbetocin Injection Market by End-user
9.1.5.2 Mexico Carbetocin Injection Market
9.1.5.2.1 Mexico Carbetocin Injection Market by Type
9.1.5.2.2 Mexico Carbetocin Injection Market by End-user
9.1.5.3 US Carbetocin Injection Market
9.1.5.3.1 US Carbetocin Injection Market by Type
9.1.5.3.2 US Carbetocin Injection Market by End-user
9.2. EUROPE
9.2.1 Europe Carbetocin Injection Market Overview
9.2.2 Europe Carbetocin Injection Market Forecasts and Analysis
9.2.3 Europe Carbetocin Injection Market Forecasts and Analysis - By Type
9.2.4 Europe Carbetocin Injection Market Forecasts and Analysis - By End-user
9.2.5 Europe Carbetocin Injection Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Carbetocin Injection Market
9.2.5.1.1 Germany Carbetocin Injection Market by Type
9.2.5.1.2 Germany Carbetocin Injection Market by End-user
9.2.5.2 France Carbetocin Injection Market
9.2.5.2.1 France Carbetocin Injection Market by Type
9.2.5.2.2 France Carbetocin Injection Market by End-user
9.2.5.3 Italy Carbetocin Injection Market
9.2.5.3.1 Italy Carbetocin Injection Market by Type
9.2.5.3.2 Italy Carbetocin Injection Market by End-user
9.2.5.4 Spain Carbetocin Injection Market
9.2.5.4.1 Spain Carbetocin Injection Market by Type
9.2.5.4.2 Spain Carbetocin Injection Market by End-user
9.2.5.5 United Kingdom Carbetocin Injection Market
9.2.5.5.1 United Kingdom Carbetocin Injection Market by Type
9.2.5.5.2 United Kingdom Carbetocin Injection Market by End-user
9.2.5.6 Rest of Europe Carbetocin Injection Market
9.2.5.6.1 Rest of Europe Carbetocin Injection Market by Type
9.2.5.6.2 Rest of Europe Carbetocin Injection Market by End-user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Carbetocin Injection Market Overview
9.3.2 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis
9.3.3 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis - By End-user
9.3.5 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Carbetocin Injection Market
9.3.5.1.1 Australia Carbetocin Injection Market by Type
9.3.5.1.2 Australia Carbetocin Injection Market by End-user
9.3.5.2 China Carbetocin Injection Market
9.3.5.2.1 China Carbetocin Injection Market by Type
9.3.5.2.2 China Carbetocin Injection Market by End-user
9.3.5.3 India Carbetocin Injection Market
9.3.5.3.1 India Carbetocin Injection Market by Type
9.3.5.3.2 India Carbetocin Injection Market by End-user
9.3.5.4 Japan Carbetocin Injection Market
9.3.5.4.1 Japan Carbetocin Injection Market by Type
9.3.5.4.2 Japan Carbetocin Injection Market by End-user
9.3.5.5 South Korea Carbetocin Injection Market
9.3.5.5.1 South Korea Carbetocin Injection Market by Type
9.3.5.5.2 South Korea Carbetocin Injection Market by End-user
9.3.5.6 Rest of Asia-Pacific Carbetocin Injection Market
9.3.5.6.1 Rest of Asia-Pacific Carbetocin Injection Market by Type
9.3.5.6.2 Rest of Asia-Pacific Carbetocin Injection Market by End-user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Carbetocin Injection Market Overview
9.4.2 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis
9.4.3 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis - By End-user
9.4.5 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Carbetocin Injection Market
9.4.5.1.1 South Africa Carbetocin Injection Market by Type
9.4.5.1.2 South Africa Carbetocin Injection Market by End-user
9.4.5.2 Saudi Arabia Carbetocin Injection Market
9.4.5.2.1 Saudi Arabia Carbetocin Injection Market by Type
9.4.5.2.2 Saudi Arabia Carbetocin Injection Market by End-user
9.4.5.3 U.A.E Carbetocin Injection Market
9.4.5.3.1 U.A.E Carbetocin Injection Market by Type
9.4.5.3.2 U.A.E Carbetocin Injection Market by End-user
9.4.5.4 Rest of Middle East and Africa Carbetocin Injection Market
9.4.5.4.1 Rest of Middle East and Africa Carbetocin Injection Market by Type
9.4.5.4.2 Rest of Middle East and Africa Carbetocin Injection Market by End-user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Carbetocin Injection Market Overview
9.5.2 South and Central America Carbetocin Injection Market Forecasts and Analysis
9.5.3 South and Central America Carbetocin Injection Market Forecasts and Analysis - By Type
9.5.4 South and Central America Carbetocin Injection Market Forecasts and Analysis - By End-user
9.5.5 South and Central America Carbetocin Injection Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Carbetocin Injection Market
9.5.5.1.1 Brazil Carbetocin Injection Market by Type
9.5.5.1.2 Brazil Carbetocin Injection Market by End-user
9.5.5.2 Argentina Carbetocin Injection Market
9.5.5.2.1 Argentina Carbetocin Injection Market by Type
9.5.5.2.2 Argentina Carbetocin Injection Market by End-user
9.5.5.3 Rest of South and Central America Carbetocin Injection Market
9.5.5.3.1 Rest of South and Central America Carbetocin Injection Market by Type
9.5.5.3.2 Rest of South and Central America Carbetocin Injection Market by End-user

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. CARBETOCIN INJECTION MARKET, KEY COMPANY PROFILES
11.1. FERRING PHARMACEUTICALS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. HYBIO PHARMACEUTICAL
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BEACON PHARMACEUTICALS LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CHENGDU SHENGNUO BIOTECHNOLOGY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. TIBET AIM PHARM INC (AIM PHARM)
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SGPHARMA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SMOKIN JOE
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MDA INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TAJ PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Ferring Pharmaceuticals
2. Hybio Pharmaceutical
3. Pfizer
4. Beacon Pharmaceuticals Ltd.
5. Chengdu Shengnuo Biotechnology
6. Tibet Aim Pharm Inc (Aim Pharm)
7. SGPharma
8. Smokin Joe
9. MDA INC.
10. Taj Pharmaceuticals
TIPRE00023795
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.